Literature DB >> 7399707

Complement activation induced by rabbit rheumatoid factor.

R R Meyer, J C Brown.   

Abstract

Rabbit rheumatoid factor produced in animals by hyperimmunized with group C streptococcal vaccine activated guinea pig complement. Anti-streptococcal serum was fractionated by Sephacryl S-200 chromatography into excluded (19S) and included (7S) material and examined for hemolytic activity in a sensitive homologous hemolytic assay system. In the presence of complement, both 19S and 7S antistreptococcal serum fractions induced lysis of bovine (ox) erythrocytes coated with mildly reduced and carboxymethylated rabbit anti-erythrocyte immunoglobulin G. That rabbit rheumatoid factor was responsible for the observed hemolytic activity was substantiated by hemolytic inhibition assays. Significant inhibition of hemolysis was effected when antistreptococcal serum fractions were incubated in the presence of human immunoglobulin G, rabbit immunoglobulin G, and Fc, whereas, no inhibition was detected when the same fractions were tested in the presence of rabbit Fab or F(ab')2 fragments. Deaggregation of inhibitor preparations revealed a preferential reactivity of rheumatoid factor for rabbit immunoglobulin G. In addition to the rheumatoid factor-dependent hemolytic activity observed in humoral preparations, immunoglobulin G-specific antibody-forming cells in spleen and peripheral blood lymphocyte isolates were enumerated by plaque-forming cell assay.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399707      PMCID: PMC551073          DOI: 10.1128/iai.29.1.50-58.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  A rabbit IgG antigenic marker detected by 19S anti-IgG present in streptococcal antisera.

Authors:  J W Chiao; V A Bokisch; C L Christian; R M Krause
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

2.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

Review 3.  The search for antibodies with molecular uniformity.

Authors:  R M Krause
Journal:  Adv Immunol       Date:  1970       Impact factor: 3.543

4.  M-antiglobulins (rheumatoid-factor-like globulins) and other gamma-globulins in relation to tropical parasitic infections.

Authors:  V Houba; A C Allison
Journal:  Lancet       Date:  1966-04-16       Impact factor: 79.321

5.  A method of increased sensitivity for detecting single antibody-forming cells.

Authors:  A J Cunningham
Journal:  Nature       Date:  1965-09-04       Impact factor: 49.962

6.  Anti-gamma globulins and chronic infection: comparative studies of the immune response to various bacteria and gamma globulin preparations.

Authors:  R C Williams; O J Mellbye; G Kronvall
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

7.  Effect of rheumatoid factor on complement-mediated phagocytosis.

Authors:  F C McDuffie; H W Brumfield
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

8.  Homogenous rabbit 7S anti-IgG with antibody specificity for peptidoglycan.

Authors:  V A Bokisch; J W Chiao; D Bernstein; R M Krause
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

9.  Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration.

Authors:  F R Schmid; I M Roitt; M J Rocha
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Occurrence of 19S and 7S anti-IgGs during hyperimmunization of rabbits with streptococci.

Authors:  V A Bokisch; D Bernstein; R M Krause
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

View more
  1 in total

1.  Preferential rheumatoid factor reactivity with disulphide bond altered IgG in radioimmunoassay.

Authors:  C S Brown; J C Brown
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.